5-hydroxydecanoate has been researched along with Kidney Diseases in 1 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
Excerpt | Relevance | Reference |
---|---|---|
"Propofol treatments were initiated at various time intervals: 1 or 24 h before ischemia, only during ischemia, or only during reperfusion." | 1.35 | The role of KATP channels on propofol preconditioning in a cellular model of renal ischemia-reperfusion. ( Assad, AR; Capella, MA; Delou, JM; Fonseca, LM; Lopes, AG; Nascimento, JH; Verçosa, N; Villela, NR, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Assad, AR | 1 |
Delou, JM | 1 |
Fonseca, LM | 1 |
Villela, NR | 1 |
Nascimento, JH | 1 |
Verçosa, N | 1 |
Lopes, AG | 1 |
Capella, MA | 1 |
1 other study available for 5-hydroxydecanoate and Kidney Diseases
Article | Year |
---|---|
The role of KATP channels on propofol preconditioning in a cellular model of renal ischemia-reperfusion.
Topics: Adenosine Triphosphate; Animals; Antimycin A; Apoptosis; Cell Survival; Cytoprotection; Decanoic Aci | 2009 |